Caribou Begins Strategic Review & Plans To Halt CAR-T Programs; Stock Plunges
(RTTNews) - On Tuesday, Caribou Biosciences, Inc. (CRBU) said it is exploring strategic alternatives to maximize stockholder value, including a potential merger, acquisition, business combination, or other strategic transactions involving the company or its assets.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
